Cite
HARVARD Citation
Tseng, S. et al. (2022). Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity. Journal for immunotherapy of cancer. 10 (4), p. . [Online].